RE: Soros and Gates back buyout of UK diagnostic technology group19 Jul 2021 09:50
While I see it as a good thing for Avacta (as per previous RNS on collaborations etc) I am going to have to do the unthinkable and agree somewhat with Turtle. I just don't see any kind of buyout of Avacta resulting from this and I just cant see AS giving up affimers (Gates/soros seem interested in diagnostics and Avactas diagnostic division is nothing without affimers). AS priority has always seemed to be therapeutics to me so I just don't see it and to be honest I am not sure I would want one at the minute.
Can only be good news for Avacta going forward though IF we can get everything powered by affimers. Another iron in the fire that makes £1.40 look dirt cheap.